VR
Venkateswara Rao Yarlagadda
About Venkateswara Rao Yarlagadda
Data last updated:
Venkateswara Rao Yarlagadda is a Director at Ritsa Pharma Private Limited (since 2021). The companies operate in Pharma. Ritsa Pharma Private Limited reported revenue of ₹9.01 Cr (FY 2025). Earlier, Venkateswara Rao Yarlagadda was a Managing Director at Sri Siri Therapeutics Private Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ritsa Pharma Private Limited U24290TG2020PTC145093 | Director | 21 Oct 2021 | 2020 | ₹9.01 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Siri Therapeutics Private Limited U24232TG2013PTC089766 | Managing Director | 01 Jun 2015 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Venkateswara Rao Yarlagadda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandrasekhar Penugonda | 10487114 | Ritsa Pharma Private Limited | Director |
| Ganji Kishore Kumar | 01973900 | Ritsa Pharma Private Limited | Director |
| Manaswini Vemulapalli | 09028514 | Ritsa Pharma Private Limited | Nominee Director |
| Narendra Babu Vutla | 03565765 | Ritsa Pharma Private Limited | Director |
| Srilalitha Bhattaram | 08880098 | Ritsa Pharma Private Limited | Director |
| Venkata Subramanya Ravi Kumar Gannavarapu | Ritsa Pharma Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkateswara Rao Yarlagadda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkateswara Rao Yarlagadda
Venkateswara Rao Yarlagadda currently holds 1 directorship: Ritsa Pharma Private Limited (Director, since 21 Oct 2021, revenue ₹9.01 Cr (FY 2025)).
Venkateswara Rao Yarlagadda was first appointed on 01 Jun 2015 as Managing Director at Sri Siri Therapeutics Private Limited. The most recent appointment on record is 21 Oct 2021 at Ritsa Pharma Private Limited.
Venkateswara Rao Yarlagadda held 1 earlier board appointment: Sri Siri Therapeutics Private Limited (Managing Director, from 01 Jun 2015).
The current boards of Venkateswara Rao Yarlagadda's companies include Chandrasekhar Penugonda (Ritsa Pharma Private Limited), Ganji Kishore Kumar (Ritsa Pharma Private Limited), Manaswini Vemulapalli (Ritsa Pharma Private Limited), Narendra Babu Vutla (Ritsa Pharma Private Limited), Srilalitha Bhattaram (Ritsa Pharma Private Limited), Venkata Subramanya Ravi Kumar Gannavarapu (Ritsa Pharma Private Limited).